计算生物学
鉴定(生物学)
基因
信号转导
生物
肺癌
生物信息学
遗传学
癌症研究
医学
病理
植物
作者
X.G. Chen,Xin Zhao,Dongbing Li,Wangjian Zha
标识
DOI:10.2174/0109298673320448240801061941
摘要
Entrectinib, a ROS1 inhibitor, is effective in patients with ROS1-positive non-small-cell lung cancer (NSCLC). However, entrectinib resistance remains a challenge worldwide. The biomarkers of entrectinib resistance and molecular mechanisms have not been clarified based on the Gene Expression Omnibus (GEO) database.
科研通智能强力驱动
Strongly Powered by AbleSci AI